Literature DB >> 2949770

Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma.

T J Yang, J P Chandler, S Dunne-Anway.   

Abstract

Canine transmissible venereal sarcoma (CTVS) is a naturally occurring contagious neoplasm which can be transplanted with intact viable cells across major histocompatibility (MHC) barriers within the species and even to other members of the canine family, such as foxes, coyotes, and wolves. After 2 to 4 months of progressive growth the tumour regresses spontaneously in adults but metastasizes in immunosuppressed hosts and neonates. The mechanisms of how the tumour cells manage to overcome histocompatibility barriers so successfully for such a long period and yet succumb later are not known. In the present study we found that CTVS cells were not stimulatory to the lymphocytes of normal or tumour-bearing animals in mixed lymphocyte-tumour reaction (MLTR), although the lymphocytes from tumour-bearing animals in mixed lymphocyte-tumour reaction (MLTR), although the lymphocytes from tumour-bearing hosts responded well to either phytohaemagglutinin (PHA) or third-party allogeneic lymphocytes. Immunofluorescent antibody (IFA) assay of MHC antigens by monoclonal antibodies (MoAb) to monomorphic Class I and Class II MHC antigens showed that progressor tumour cells lacked the expression of the antigens whereas 30 to 40% of regressor tumour cells expressed them.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949770      PMCID: PMC2002089          DOI: 10.1038/bjc.1987.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  The biological behaviour of the transmissible venereal tumour in immunosuppressed dogs.

Authors:  D Cohen
Journal:  Eur J Cancer       Date:  1973-04       Impact factor: 9.162

2.  Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?

Authors:  P Alexander
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

Review 3.  The canine transmissible venereal tumor: a unique result of tumor progression.

Authors:  D Cohen
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Chromosome studies of a transplanted and a primary canine venereal sarcoma.

Authors:  W T Weber; P C Nowell; W C Hare
Journal:  J Natl Cancer Inst       Date:  1965-09       Impact factor: 13.506

5.  Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).

Authors:  M W Harding; T J Yang
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene.

Authors:  K Tanaka; K J Isselbacher; G Khoury; G Jay
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

7.  Histocompatibility typing and course of canine venereal tumors transplanted into unmodified random dogs.

Authors:  R B Epstein; B T Bennett
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

8.  Tumor-blocking and -inhibitory serum factors in the clinical course of canine venereal tumor.

Authors:  B T Bennett; K M Debelak-Fehir; R B Epstein
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

9.  Canine transmissible venereal sarcoma: quantitation of T-lymphocyte subpopulations during progressive growth and spontaneous tumor regression.

Authors:  P A Trail; T J Yang
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

10.  Canine transmissible venereal sarcoma: transplantation studies in neonatal and adult dogs.

Authors:  T J Yang; J B Jones
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

View more
  7 in total

1.  Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.

Authors:  T J Yang; T J Palker; M W Harding
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  The role of the Major Histocompatibility Complex in the spread of contagious cancers.

Authors:  Katherine Belov
Journal:  Mamm Genome       Date:  2010-10-21       Impact factor: 2.957

3.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

4.  Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams.

Authors:  Michael J Metzger; Carol Reinisch; James Sherry; Stephen P Goff
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

5.  Immunology of naturally transmissible tumours.

Authors:  Hannah V Siddle; Jim Kaufman
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

6.  The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.

Authors:  Alison Caldwell; Rachel Coleby; Cesar Tovar; Maximilian R Stammnitz; Young Mi Kwon; Rachel S Owen; Marios Tringides; Elizabeth P Murchison; Karsten Skjødt; Gareth J Thomas; Jim Kaufman; Tim Elliott; Gregory M Woods; Hannah Vt Siddle
Journal:  Elife       Date:  2018-08-14       Impact factor: 8.140

Review 7.  Testing the theory of immune selection in cancers that break the rules of transplantation.

Authors:  Ariberto Fassati; N Avrion Mitchison
Journal:  Cancer Immunol Immunother       Date:  2009-12-22       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.